Related Experiment Video
Updated: Jul 16, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study
Roseanne DeFronzo Dobkin1, Lesley A Allen, Matthew Menza
1Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA. dobkinro@umdnj.edu
Summary
This study shows that modified cognitive-behavioral treatment (CBT) is a feasible and effective option for treating depression in Parkinson's disease (PD) patients. Caregiver support also improved patient outcomes and was maintained at follow-up.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Psychology
Background:
- Parkinson's disease (PD) is often accompanied by Major Depressive Disorder (MDD).
- Standard treatments may not fully address the unique challenges faced by PD patients with depression.
- Caregiver support is crucial but often overlooked in PD depression interventions.
Purpose of the Study:
- To assess the feasibility and effectiveness of an adapted individual cognitive-behavioral treatment (CBT) for depression in PD patients.
- To evaluate the impact of a separate social support intervention for caregivers of PD patients with depression.
- To determine if treatment gains are maintained post-intervention.
Main Methods:
- Fifteen PD patients diagnosed with MDD participated with their caregivers.
- Patients received 10-14 sessions of modified individual CBT tailored for PD.
- Caregivers attended 3-4 separate psychoeducational sessions focused on support strategies.
Main Results:
- PD patients showed significant reductions in depressive symptoms and negative cognitions.
- Patients reported an increased perception of social support during the treatment.
- Treatment benefits were sustained at a 1-month follow-up assessment.
Conclusions:
- Modified individual CBT appears to be a feasible and effective approach for managing depression in Parkinson's disease.
- Integrated caregiver support may enhance patient outcomes in PD depression.
- Further research, including larger randomized controlled trials, is warranted to confirm efficacy and explore mechanisms of change.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:25Cognitive Therapy
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...